Foresite Capital Management IV’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $25.7M | Hold |
|
|||||
|
2023
Q4 | $22.9M | Hold |
|
|||||
|
2023
Q3 | $13.5M | Hold |
|
|||||
|
2023
Q2 | $29.3M | Hold |
|
|||||
|
2023
Q1 | $60.4M | Hold |
|
|||||
|
2022
Q4 | $59M | Hold |
|
|||||
|
2022
Q3 | $116M | Hold |
|
|||||
|
2022
Q2 | $122M | Hold |
|
|||||
|
2022
Q1 | $109M | Hold |
|
|||||
|
2021
Q4 | $171M | Hold |
|
|||||
|
2021
Q3 | $223M | Hold |
|
|||||
|
2021
Q2 | $225M | Hold |
|
|||||
|
2021
Q1 | $301M | Hold |
|
|||||
|
2020
Q4 | $385M | Buy |
|